Società Calmare Therapeutics Incorporated Other OTC
Azioni
CTTC
US13126R1023
Attrezzatura medica
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Conrad Mir
CEO | Chief Executive Officer | 55 | 27/09/13 |
Director of Finance/CFO | 71 | - | |
Donna Mays
ADM | Chief Administrative Officer | - | - |
Stephen D'Amato
CTO | Chief Tech/Sci/R&D Officer | - | - |
William Lipford
SAM | Sales & Marketing | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Rustin Howard
BRD | Director/Board Member | 67 | 01/10/07 |
Conrad Mir
CEO | Chief Executive Officer | 55 | 27/09/13 |
Stanley Yarbro
BRD | Director/Board Member | 74 | - |
Peter Brennan
CHM | Chairman | 69 | 06/06/11 |
Santanu Das
BRD | Director/Board Member | - | 12/07/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 38 997 971 | 38 997 971 ( 100,00 %) | 0 | 99,99 % |
Azione B | 0 | 2 427 | 0 | 0 |
Coordinate società
Calmare Therapeutics, Inc.
2 Trap Falls Road Suite 507
06484, Shelton
+
http://www.calmaretherapeutics.com![Indirizzo Calmare Therapeutics Incorporated(CTTC)](https://cdn.zonebourse.com/static/address/23689346.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+2,24% | 205 Mrd | |
+6,45% | 179 Mrd | |
+31,46% | 158 Mrd | |
+33,00% | 113 Mrd | |
+4,87% | 64,93 Mrd | |
+21,77% | 56,51 Mrd | |
-2,92% | 46,36 Mrd | |
-5,91% | 37,07 Mrd | |
+3,39% | 36,12 Mrd |